Officials at Sequent Medical Inc. announce the company has received CE mark for the VIA Microcatheter and is initiating commercial introduction of this new product family in select markets.
The VIA will be used for delivery and deployment of Sequent's WEB Aneurysm Embolization System, which is utilized to treat cerebral aneurysms. The VIA is currently available in two models, the VIA and the VIA PLUS.
"The VIA Microcatheter provides an optimal combination of properties for stable WEB placement, retrieval and navigability and will enable physicians to treat a broader range of aneurysm with the WEB," says PD Dr. med. Werner Weber, Head of the Department of Radiology and Interventional Neuroradiology, Klinikum Vest, Knappschaftskrankenhaus, Recklinghausen, Germany.
"Combined with planned additions to our WEB platform, the VIA demonstrates Sequent Medical's ongoing commitment to developing a broad portfolio of innovative catheter-based technologies for neurovascular specialists and their patients," says Tom Wilder, president and CEO.